Clinical Care Options 의 CCO Infectious Disease Podcast
Clinical Care Options
카테고리: 교육
마지막 에피소드 듣기:
이전 에피소드
-
381 - Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma Thu, 11 Apr 2024
-
380 - Linkage to Care After HBV Diagnosis: Sharing Session 3 Wed, 10 Apr 2024
-
379 - Key HIV Studies From CROI 2024 Influencing Clinical Practice Fri, 29 Mar 2024
-
378 - How to Implement Earlier Hepatitis B Treatment Tue, 26 Mar 2024
-
377 - Empowering Patients With Education on HBV: Sharing Session 2 Mon, 11 Mar 2024
-
376 - Switching HIV ART in Older People With Weight Gain and Cardiovascular Comorbidities Fri, 8 Mar 2024
-
375 - Optimizing ART in Priority Populations: Initiating ART in Transgender Women Mon, 4 Mar 2024
-
374 - COVID-19 Case Challenges: Employing Outpatient Antivirals and Addressing Drug‒Drug Interactions Tue, 27 Feb 2024
-
373 - New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023 Mon, 5 Feb 2024
-
372 - Reconsidering Your Approach: Strategies to Support PrEP Persistence and Reengagement Wed, 31 Jan 2024
-
371 - My Journey With HBV and HDV: Sharing Session 1 Wed, 24 Jan 2024
-
370 - Why I Started and Why I Stayed on HIV PrEP Fri, 12 Jan 2024
-
369 - Long-Acting PrEP: Strategies to Support PrEP Persistence and Reengagement Wed, 10 Jan 2024
-
368 - RSV Vaccines in Adults: A Risk-Based Approach Wed, 27 Dec 2023
-
367 - How to Implement Earlier Hepatitis B and Hepatitis Delta Screening Fri, 22 Dec 2023
-
366 - Q&A on HIV PrEP: Episode 7 for Advanced Practice Providers Thu, 21 Dec 2023
-
365 - Mental Health Challenges: Dialogues on Optimizing Engagement in HIV Care Wed, 20 Dec 2023
-
364 - Starting ART: Dialogues on Optimizing Engagement in HIV Care Mon, 18 Dec 2023
-
363 - Engagement in Care: Dialogues on Optimizing Engagement in HIV Care Mon, 18 Dec 2023
-
362 - Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement Fri, 15 Dec 2023
-
361 - Selected FXR Agonist PBC Studies: Conference Coverage of AASLD Wed, 13 Dec 2023
-
360 - PrEP Talks: Strategies for Advanced Practice Providers to Increase Uptake Tue, 12 Dec 2023
-
359 - Where We Want to Be: The Search for a Cure for HIV Mon, 11 Dec 2023
-
358 - CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia Thu, 7 Dec 2023
-
357 - Investigational PPAR-delta Agonist for PBC Treatment and Race-Based Considerations for PBC Diagnosis: Conference Coverage of AASLD Thu, 7 Dec 2023
-
356 - PrEP Talks: Uptake in Young Adults and Adolescents Thu, 7 Dec 2023
-
355 - Investigational Dual PPAR Agonist, FXR Agonist With Fibrate, and Hyperlipidemia in People With PBC: Conference Coverage of AASLD Wed, 6 Dec 2023
-
354 - Are We Making Our Patients Fight for PrEP? Mon, 4 Dec 2023
-
353 - Q&A on HIV PrEP: Episode 6 on Cisgender Women Mon, 4 Dec 2023
-
352 - The Rise of RSV: Updates on Seasonality Thu, 30 Nov 2023
-
351 - Ready, Set, Vaccinate! RSV Vaccination for Older Adults Thu, 30 Nov 2023
-
350 - A Difficult Differential: Clinical Presentation and Diagnosis of RSV in Adults Thu, 30 Nov 2023
-
349 - Q&A on HIV PrEP: Episode 4 on Adolescents and Young Adults Part 2 Thu, 30 Nov 2023
-
347 - Podcast on On-Demand PrEP: Strategies to Support PrEP Persistence and Reengagement Thu, 30 Nov 2023
-
346 - Role of Quantitative HBsAg Testing in Clinical Practice for People With CHB Wed, 29 Nov 2023
-
345 - Which Patients With Hepatitis B Should We Be Treating? Wed, 29 Nov 2023
-
344 - A Hidden Annual Epidemic: The Burden of RSV in Adults Wed, 29 Nov 2023
-
343 - Podcast on Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement Tue, 28 Nov 2023
-
342 - Trailblazers: Pharmacist’s Role in Optimizing New RSV Vaccines for Older Adults Mon, 27 Nov 2023
-
341 - Light on the Horizon: Developments in RSV Vaccines Tue, 21 Nov 2023
-
340 - Surveying the Landscape: Annual Burden of RSV in Older Adults Tue, 21 Nov 2023
-
339 - Q&A on HIV PrEP: Episode 5 on Transgender Individuals and Racial and Ethnic Minority Men Who Have Sex With Men Part 2 Tue, 21 Nov 2023
-
338 - NDM-Producing Enterobacterales: Applying Best Practices in Complex Clinical Scenarios Thu, 16 Nov 2023
-
337 - DTR-Pseudomonas aeruginosa: Applying Best Practices in Complex Clinical Scenarios Thu, 16 Nov 2023
-
336 - Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios Wed, 15 Nov 2023
-
335 - Where We’re Going: The Next Wave of Antiretroviral Innovations Wed, 15 Nov 2023
-
334 - PrEP Today: An HIV Prevention Revolution Mon, 13 Nov 2023
-
333 - Unlocking the Promise of PrEP and the Future of PrEP Mon, 13 Nov 2023
-
332 - Updates in Antimicrobial Selection for uUTIs Mon, 13 Nov 2023
-
331 - Best Practices in Managing Uncomplicated UTIs in the Emergency Department Mon, 13 Nov 2023
더 많은 에피소드 표시
5